FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA

Their core work

The Carlo Besta Neurological Institute is Italy's leading dedicated neuroscience research hospital (IRCCS), combining clinical neurology with translational research. Their H2020 work spans neurological disease progression modeling, pain mechanisms, neuroglia pathology, brain tumor clinical trials, and workplace mental health interventions. They bring deep clinical neuroscience expertise — from rare neurological conditions to large-scale epidemiological studies on ageing and brain health. Their dual identity as both a treating hospital and a research center means they can contribute real patient data and clinical validation to European consortia.

What they specialise in

How they've shifted over time

Their early H2020 portfolio (2015–2018) was rooted in classical clinical neuroscience: ageing trajectories, neurological disease modeling, microfluidic diagnostics for chemotherapy, and neuroglia training networks. From 2020 onward, their most recent project (EMPOWER) signals a notable expansion into occupational mental health — tackling depression, anxiety, stress, and workplace wellbeing. This suggests the institute is broadening from purely neurological conditions toward the wider mental health and psychosocial domain, likely reflecting growing EU funding priorities around workplace health.

Moving from pure clinical neurology toward applied mental health and wellbeing — potential partners in occupational health, eHealth, and psychosocial intervention projects should take note.

How they like to work

Primarily a consortium partner (6 of 7 projects), contributing specialized clinical neuroscience expertise to larger teams rather than leading them. Their one coordination — PAIN-Net, an MSCA training network — suggests they can lead when the topic aligns tightly with their institutional strength in pain research. With 83 unique partners across 19 countries, they are well-networked and comfortable working in large, diverse European consortia.

Broad European network with 83 unique consortium partners across 19 countries, indicating they are a trusted and sought-after clinical neuroscience partner. No single geographic cluster dominates — their reach is genuinely pan-European.

What sets them apart

As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Carlo Besta holds a special Italian designation for hospitals that conduct high-level translational research — meaning they can provide both clinical patient access and rigorous research outputs in neuroscience. Their pain research coordination (PAIN-Net) and participation in a glioma clinical trial demonstrate an ability to bridge from bench to bedside. For consortium builders, they offer something rare: a single partner covering neurological disease data, clinical trial infrastructure, and increasingly, mental health intervention expertise.

Highlights from their portfolio

• PAIN-Net
  Their only coordinated H2020 project, a molecule-to-man pain research training network — signals pain neuroscience as their flagship institutional competence.
• EuroPOND
  Their largest single grant (EUR 337,306), focused on data-driven modeling of neurological disease progression — a computationally intensive area showing their quantitative research capacity.
• EMPOWER
  Their most recent project (2020-2024), marking a strategic expansion from clinical neurology into workplace mental health, eHealth interventions, and psychosocial wellbeing.